September 30, 2008

U.S. District Court in Delaware Enters Final Judgment of Approximately $1.2 Billion to Cordis Corporation on Patents Infringed by Medtronic, Inc. and Boston Scientific Corporation

MIAMI LAKES, Fla., Sept 30, 2008 /PRNewswire via COMTEX News Network/ -- The U.S. District Court in Delaware today entered final judgment including accrued interest, totaling approximately $1.2 billion, to Cordis Corporation against Medtronic, Inc. and Boston Scientific Corporation in cases involving the original Palmaz balloon expandable stent patent. Juries in 2000 and 2005 found that Boston Scientific's and Medtronic's bare metal stents infringed the Palmaz patent, which is owned by Cordis Corporation. Medtronic was ordered to pay approximately $521 million and Boston Scientific approximately $703 million.

The company is pleased that a judgment was entered and that the patent for Dr. Palmaz's groundbreaking product has been acknowledged.

Cordis Corporation, a Johnson & Johnson company, is a worldwide leader in the development and manufacture of interventional vascular technology. Through the company's innovation, research and development, Cordis partners with interventional cardiologists worldwide to treat millions of patients who suffer from vascular disease. More information about Cordis Corporation can be found at

SOURCE Cordis Corporation

Copyright (C) 2008 PR Newswire. All rights reserved

News Provided by COMTEX

Close window | Back to top

Copyright 2015 Johnson & Johnson

This site is governed solely by applicable U.S laws and governmental regulations. Please see our Privacy Policy. Use of this site constitutes your consent to application of such laws and regulations and to our Privacy Policy.Your use of the information on this site is subject to the terms of our Legal Notice. You should view the News section and the most recent SEC Filings in the Investor section in order to receive the most current information made available by Johnson & Johnson.Contact Us with any questions or search this site for more information.